Santos, R.A.S. and Ferreira, A.J. (2006) Pharmacological Effects of AVE 0991, a Nonpeptide Angiotensin-(1–7) Receptor Agonist. Cardiovascular Drug Reviews, 24, 239-246.
https://doi.org/10.1111/j.1527-3466.2006.00239.x

has been cited by the following article:

• TITLE: The Role for AVE0991 (MAS-Receptor Angiotensin II (1-7) Agonist) in Reducing Cisplatin-Induced Acute Kidney Injury on C57BL/6 Mice

  AUTHORS: Chris Mathew

  KEYWORDS: Cisplatin, Acute Kidney Injury, AKI, Cisplatin-Induced Acute Kidney Injury, Nephrotoxicity, Renal Renin Angiotensin System, RAS, AVE0991, MAS-Receptor Angiotensin II (1-7) Agonist

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.11 No.1, January 31, 2023

  ABSTRACT: Acute Kidney Injury (AKI) is a condition that causes nephrotoxicity in kidney tissues due to cisplatin-induced cancer treatments. Hence, it is proposed in this review that AVE0991 (a MAS-receptor Angiotensin II (1-7) agonist) may reduce cisplatin-induced acute kidney injury by promoting nitric oxide production.